Veterinary Clinical Reference

Look up any drug or condition.

Evergreen, evidence-based hubs on the drugs, conditions, and species you manage — continuously updated and cited at every claim.

197 evergreen hubsCited at every claimContinuously updatedFree for verified vets
CanineAug 6, 2026

Salt Toxicosis and Hypernatraemia in Dogs: A Clinical Reference

Salt toxicosis kills through correction, not concentration. Exposure sources, the sodium thresholds that matter, free water deficit, and the maximum safe correction rate for acute versus chronic hypernatraemia in dogs.

Read →
CanineJul 31, 2026

Lead Toxicosis in Dogs: Diagnosis and Chelation Therapy

An ER/toxicology reference for lead poisoning in dogs (cats noted): sources, the combined GI-neurologic presentation, basophilic stippling and nRBCs, whole-blood lead thresholds, radiography, and the stabilize-remove GI lead-chelate sequence with exact CaEDTA, succimer, and D-penicillamine doses.

Read →
CanineJul 30, 2026

Zinc Toxicosis in Dogs: Sources, Hemolysis, Diagnosis, and Treatment

Canine zinc toxicosis causes intravascular hemolysis, hemoglobinuria, and multi-organ injury, usually from a swallowed post-1982 penny or galvanized metal. A clinical reference on zinc sources, the royal-blue-top tube pitfall, source removal, and the chelation debate.

Read →
CanineJul 10, 2026

Methylxanthine (Chocolate & Caffeine) Toxicosis in Dogs

ER reference for canine methylxanthine (chocolate/caffeine) toxicosis: theobromine/caffeine MOA and kinetics, mg/kg dose thresholds, chocolate-type ranking, decontamination, and symptomatic management of tachyarrhythmia, seizures, and hyperthermia.

Read →
CanineJul 10, 2026

Grape & Raisin Nephrotoxicosis in Dogs: AKI Management

Clinical reference on grape, raisin, and tamarind nephrotoxicosis in dogs: the idiosyncratic (no safe-dose) nature, the 2022 tartaric-acid hypothesis, the biphasic GI-then-AKI timeline, decontamination, fluid diuresis with serial renal-value monitoring, and prognosis by oliguric status.

Read →
CanineJul 9, 2026

Anticoagulant Rodenticide Toxicosis in Dogs: Clinical Management

A DVM's clinical reference for anticoagulant rodenticide toxicosis in dogs: mechanism, delayed 3-5 day presentation, PT as the earliest marker, vitamin K1 antidotal dosing and duration by generation, plasma for active bleeding, and the recheck-PT-after-stopping rule.

Read →
CanineJul 8, 2026

Xylitol Toxicosis in Dogs: Clinical Management

A DVM reference for xylitol toxicosis in dogs: hypoglycemia at ~0.1 g/kg and hepatic necrosis at ~0.5 g/kg, delayed onset, why activated charcoal fails, and dextrose plus hepatoprotectant protocols with monitoring intervals and prognosis.

Read →
CanineJul 8, 2026

Sago Palm (Cycad) Hepatotoxicosis in Dogs: Clinical Management

A clinical reference for managing sago palm (Cycas revoluta) toxicosis in dogs: cycasin/MAM mechanism, the three-phase course, decontamination with multi-dose activated charcoal, hepatoprotectant dosing (NAC, SAMe, silymarin), coagulopathy management, monitoring, and prognosis.

Read →
CanineJul 8, 2026

Cannabis (THC) Toxicosis in Dogs: Emergency Management

A point-of-care clinical reference for THC toxicosis in dogs: toxicokinetics, the neurologic hallmark, decontamination criteria, supportive care and intravenous lipid emulsion dosing, the edible co-toxin trap, and prognosis.

Read →